The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study to evaluate surufatinib combined with camrelizumab and chemotherapy in the second-line treatment of advanced colorectal cancer: Phase Ib results.
 
Sheng Li
No Relationships to Disclose
 
Liangjun Zhu
No Relationships to Disclose
 
Xiaoyou Li
No Relationships to Disclose
 
Jiayuan Huang
No Relationships to Disclose
 
Jun Bao
No Relationships to Disclose